Development and validation of metabolic models for predicting survival and immune status of hepatocellular carcinoma patients.

Li, Xueying; Gu, Mengli; Hu, Qiying; Weng, Yihui; Cai, Xianlei

Li, Xueying; Gu, Mengli; Hu, Qiying; Weng, Yihui; Cai, Xianlei.

Affiliation

Li X; Department of Gastroenterology, Ningbo First Hospital, Ningbo University, China.
Gu M; Department of Gastroenterology, Ningbo First Hospital, Ningbo University, China.
Hu Q; Department of Gastroenterology, Ningbo First Hospital, Ningbo University, China.
Weng Y; Department of Gastrointestinal Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo University, China.
Cai X; Department of Gastrointestinal Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo University, China.

Adv Clin Exp Med ; 32(12): 1423-1439, 2023 Dec.

Article in En | MEDLINE | ID: mdl-37166013

Subject(s)

Carcinoma, Hepatocellular; Liver Neoplasms; Humans; Carcinoma, Hepatocellular/genetics; Liver Neoplasms/genetics; Lipid Metabolism; Disease-Free Survival; Fatty Acids

Key words

fatty acid metabolism; glycolysis; hepatocellular carcinoma; immune status; prognostic models

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Adv Clin Exp Med Year: 2023 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google